Drug Pricing

Securing Affordable Treatments for All Americans

Anticompetitive practices within the pharmaceutical industry, coupled with outdated patent laws that inhibit more affordable biosimilars and generics, have resulted in skyrocketing drug costs for all Americans – but especially seniors and those with chronic conditions. ACHP advocates for sensible policies such as price transparency to rein in sky-high costs so that patients can afford the medications they need.

Facts & Figures

icon

ACHP plans partner with

Civica Rx

to address drug shortages and high prices.

image-card

FACT SHEET — Curbing High Drug Costs

Download
Resource Library Search

ACHP Letter to CMS on Broker Payment Reform

ACHP sent a letter to CMS encouraging the Administration to include policy recommendations in MA for Tomorrow in the Contract Years 2025 Part C and D Policy and Technical Changes …

09/22/2023

ACHP’s MA for Tomorrow FAQ Sheet

ACHP released a set of Frequently Asked Questions to support MA for Tomorrow, our vision for Medicare Advantage.

ACHP Letter to CMS on Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems

ACHP sent a comment letter to CMS on the Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs proposed rule.

09/11/2023

ACHP Letter to CMS on Short-Term, Limited-Duration Insurance Plans

ACHP submitted a letter to CMS on the STLDI proposed rule designed to support enhanced consumer experience and greater competition and efficiency in the marketplace.

09/11/2023

ACHP Statement on the Announcement of the First Ten Drugs to be Negotiated in the IRA

As the only national payer organization that supported robust drug pricing reform, including allowing direct government negotiation for drugs without competition, we are pleased by the White House’s announcement of …

08/29/2023

Loading…
Making Health Care Better

ACHP is the voice of a unique approach in health care today, one that puts the patient at the center with plans and clinical teams collaborating to improve health outcomes and reduce costs. Our advocacy focuses on providing policymakers with tested solutions, rooted in a model that is proven to deliver better value for patients, employers and taxpayers.

icon-arrow
client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo
icon-arrow

Stay Connected